Differential assessment of airway inflammation in chronic obstructive pulmonary disease (COPD) by measurements of exhaled nitric oxide (NO) derived from peripheral vs. central airways

C. Brindicci, S. C. George, P. J. Barnes, S. A. Kharitonov (Bari, Italy; Irvine, United States Of America; London, United Kingdom)

Source: Annual Congress 2003 - Exhaled breath techniques and other aspects of lung inflammation
Session: Exhaled breath techniques and other aspects of lung inflammation
Session type: Thematic Poster Session
Number: 1814
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Brindicci, S. C. George, P. J. Barnes, S. A. Kharitonov (Bari, Italy; Irvine, United States Of America; London, United Kingdom). Differential assessment of airway inflammation in chronic obstructive pulmonary disease (COPD) by measurements of exhaled nitric oxide (NO) derived from peripheral vs. central airways. Eur Respir J 2003; 22: Suppl. 45, 1814

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differential assessment of airway inflammation and anti-inflammatory treatment in asthma by measurements of exhaled nitric oxide (NO) derived from peripheral versus central airways
Source: Eur Respir J 2003; 22: Suppl. 45, 449s
Year: 2003

Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function
Source: Eur Respir J 2001; 17: 934-938
Year: 2001



Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Can fractional exhaled nitric oxide be useful to differentiate asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) from COPD-only
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Correlation between exhaled nitric oxide, airway hyper responsiveness and pulmonary function data in patients with suspected asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009


Exhaled nitric oxide in respiratory diseases other than asthma
Source: Eur Respir Monogr 2010; 49: 45-55
Year: 2010


Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma
Source: Eur Respir J 2006; 27: 951-956
Year: 2006



Extended exhaled nitric oxide measurements at different exhalation flows may differentiate between bronchial airways and alveolar inflammation in patients with asthma and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 174s
Year: 2002

Nitric oxide and oxygen inhalation during exercise in patients with chronic obstructive lung disease (COPD) and secondary pulmonary hypertension (PH)
Source: Eur Respir J 2001; 18: Suppl. 33, 83s
Year: 2001

Value of induced sputum nitric oxide and 3-Nitrotyrosine(3NT) levels in differentiating obstructive and inflammatory diseases of lung
Source: Eur Respir J 2003; 22: Suppl. 45, 268s
Year: 2003

Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)?
Source: International Congress 2017 – Lung function testing in different patient categories
Year: 2017


Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019

Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms
Source: Eur Respir J 2002; 20: 841-845
Year: 2002



Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 439-443
Year: 2003



Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Two sites of airway obstruction identified by post-bronchodilation change of exhaled nitric oxide in COPD patients
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016


Use of different exhaled nitric oxide multiple flow rate models in COPD
Source: Eur Respir J 2007; 29: 651-659
Year: 2007



Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study
Source: Eur Respir J 2002; 20: 332-338
Year: 2002



Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 344-349
Year: 2008